The Christie NHS Foundation Trust

Specialist MDT: The Christie NHS Foundation Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services (updated 2019):

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under general anaesthetic
    • Choline PET
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy
    • Intensity-modulated radiotherapy
    • Low-dose rate brachytherapy
    • High-dose rate brachytherapy
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
    • Joint specialist MDT clinic
  • Support Service Facilities:
    • Prostate cancer clinical nurse specialist (PCa CNS)
    • Advanced PCa CNS
    • Urology CNS
    • Oncology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 59 59
Performance Status recorded 2% 2%
PSA completed 3% 3%
Gleason Score completed 81% 81%
TNM completed 49% 49%
Risk group assigned 81% 81%

Disease Presentation

Specialist MDT National
No. of men with disease status determined N/A 49027
Percentage of men diagnosed with metastatic disease 0% 13%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 10 3055
Percentage of men with low-risk localised disease receiving radical treatment 0% 5%
No. of men diagnosed with locally advanced disease 12 19663
Percentage of men diagnosed with locally advanced disease receiving radical treatment 39% 71%
No. of men diagnosed with M1 (metastases) 3 6136
Percentage of men diagnosed with M1 (metastases) receiving docetaxel 0% 36%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2018-2019) 168
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 15%
No. of men who received radical prostatectomy (2017) 76
Adjusted percentage of men experiencing at least one GU complication requiring a procedural/surgical intervention (%) 11%
No. of men who received radical radiotherapy (2017) 517
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%) 15%

Patient-reported outcomes

Treatment Centre
No. of men diagnosed 1st April 18 - 30th Sept 18 who received radical prostatectomy and were sent a questionnaire 56
Percentage of men who responded 70%
No. of men who completed sufficient information for a validated EPIC-26 urinary incontinence score to be determined 37
Adjusted EPIC-26 urinary incontinence score (0=worst to 100=best) 75
No. of men who completed sufficient information for a validated EPIC-26 sexual function score to be determined 38
Adjusted EPIC-26 sexual function score (0=worst to 100=best) 17
No. of men diagnosed 1st April 18 - 30th Sept 18 who received external beam radiotherapy and were sent a questionnaire 301
Percentage of men who responded 77%
No. of men who completed sufficient information for a validated EPIC-26 bowel function score to be determined 197
Adjusted EPIC-26 bowel function score (0=worst to 100=best) 81
No. of men who completed sufficient information for a validated EPIC-26 sexual function score to be determined 218
Adjusted EPIC-26 sexual function score (0=worst to 100=best) 18

Compare provider outcomes